Cell surface engineering and application in cell delivery to heart diseases

Cell-based therapy has expanded its influence in cancer immunotherapy, regenerative medicine, and tissue engineering. Due to their secretory functions, differentiation capabilities, specific homing effects through chemotaxis, distinctive therapeutic potentials, and ex vivo expandability, cells have become an attractive reagent for advanced therapeutic strategies. Therefore, the ability to modify cells and manipulate their functions according to intended therapeutic designs has been the central scientific interest in the field of biomedical research. Many innovative methods have been developed with genetic modification of cells being the most advanced cell surface engineering technique. Although genetic modification is a powerful tool, it has a limited applicability due to the permanent modifications made on cells. Alternatively, many endeavors have been made to develop surface engineering techniques that can circumvent the limitations of genetic modification. In this review, current methods of non-genetic cell surface modification, including chemical conjugations, polymeric encapsulation, hydrophobic insertion, enzymatic and metabolic addition, will be introduced. Moreover, cell surface engineering plausible for cardiac remodeling and the future prospective will be discussed at the end.

[1]  J. Cohn,et al.  Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling. , 2000, Journal of the American College of Cardiology.

[2]  Carolyn R. Bertozzi,et al.  Noncovalent cell surface engineering: incorporation of bioactive synthetic glycopolymers into cellular membranes. , 2008, Journal of the American Chemical Society.

[3]  Stefan Schinkinger,et al.  The regulatory role of cell mechanics for migration of differentiating myeloid cells , 2009, Proceedings of the National Academy of Sciences.

[4]  A. Freitas,et al.  Altered fatty acid membrane composition modifies lymphocyte localization in vivo. , 1987, Cellular immunology.

[5]  Y. Tang,et al.  Mobilizing of haematopoietic stem cells to ischemic myocardium by plasmid mediated stromal-cell-derived factor-1alpha (SDF-1alpha) treatment. , 2005, Regulatory peptides.

[6]  R. Zhao,et al.  Regulation of CXCR4 expression in human mesenchymal stem cells by cytokine treatment: role in homing efficiency in NOD/SCID mice. , 2007, Haematologica.

[7]  R. Arens,et al.  Improving Adoptive T Cell Therapy: The Particular Role of T Cell Costimulation, Cytokines, and Post-Transfer Vaccination , 2016, Front. Immunol..

[8]  C. Bertozzi,et al.  Cell surface engineering by a modified Staudinger reaction. , 2000, Science.

[9]  A. Bayés‐Genís,et al.  Mesenchymal stem cells for cardiac repair: are the actors ready for the clinical scenario? , 2017, Stem Cell Research & Therapy.

[10]  R. Mebius,et al.  Structure and function of the spleen , 2005, Nature Reviews Immunology.

[11]  Kai Simons,et al.  Lipid Rafts As a Membrane-Organizing Principle , 2010, Science.

[12]  J. Kastrup,et al.  Bone marrow-derived mesenchymal stromal cell treatment in patients with severe ischaemic heart failure: a randomized placebo-controlled trial (MSC-HF trial). , 2015, European heart journal.

[13]  Sudha Kumari,et al.  Endocytosis unplugged: multiple ways to enter the cell , 2010, Cell Research.

[14]  P. Pattany,et al.  Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity , 2009, Proceedings of the National Academy of Sciences.

[15]  Joshua M Hare,et al.  Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[16]  John D Lambris,et al.  Can cells and biomaterials in therapeutic medicine be shielded from innate immune recognition? , 2010, Trends in immunology.

[17]  R. Childs,et al.  Genetic Manipulation of NK Cells for Cancer Immunotherapy: Techniques and Clinical Implications , 2015, Front. Immunol..

[18]  H. Iwata,et al.  Cell surface modification with polymers for biomedical studies , 2010 .

[19]  W. Pu,et al.  Strategies for Cardiac Regeneration and Repair , 2014, Science Translational Medicine.

[20]  A. Gliozzi,et al.  Multilayer nanoencapsulation. New approach for immune protection of human pancreatic islets. , 2006, Nano letters.

[21]  P. Walczak,et al.  Genetic Engineering of Mesenchymal Stem Cells to Induce Their Migration and Survival , 2016, Stem cells international.

[22]  W. Rombouts,et al.  Primary murine MSC show highly efficient homing to the bone marrow but lose homing ability following culture , 2003, Leukemia.

[23]  Carolyn R. Bertozzi,et al.  Copper-free click chemistry for dynamic in vivo imaging , 2007, Proceedings of the National Academy of Sciences.

[24]  M. Maitz,et al.  Blood coagulation on biomaterials requires the combination of distinct activation processes. , 2009, Biomaterials.

[25]  E. Chaikof,et al.  Layer-by-layer assembly of a conformal nanothin PEG coating for intraportal islet transplantation. , 2008, Nano letters.

[26]  Paul D. Kessler,et al.  Human Mesenchymal Stem Cells Differentiate to a Cardiomyocyte Phenotype in the Adult Murine Heart , 2002, Circulation.

[27]  P. Madeddu,et al.  Stem cell therapy for cardiovascular disease: the demise of alchemy and rise of pharmacology , 2013, British journal of pharmacology.

[28]  P. Sluijs,et al.  How proteins move lipids and lipids move proteins , 2001, Nature Reviews Molecular Cell Biology.

[29]  H. Iwata,et al.  Retention dynamics of amphiphilic polymers PEG-lipids and PVA-Alkyl on the cell surface. , 2010, ACS applied materials & interfaces.

[30]  A. Torres,et al.  Exploiting cell surface thiols to enhance cellular uptake. , 2012, Trends in biotechnology.

[31]  Teruyuki Nagamune,et al.  Poly(ethylene glycol)-Lipid-Conjugated Antibodies Enhance Dendritic Cell Phagocytosis of Apoptotic Cancer Cells , 2012, Pharmaceuticals.

[32]  G. Bell,et al.  One-Step Enzymatic Modification of the Cell Surface Redirects Cellular Cytotoxicity and Parasite Tropism , 2014, ACS chemical biology.

[33]  G. Meer,et al.  Membrane lipids: where they are and how they behave , 2008, Nature Reviews Molecular Cell Biology.

[34]  L. Ou,et al.  Targeted migration of mesenchymal stem cells modified with CXCR4 gene to infarcted myocardium improves cardiac performance. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[35]  Ling Wei,et al.  Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis. , 2008, The Journal of thoracic and cardiovascular surgery.

[36]  K. Poss,et al.  Cardiac regeneration strategies: Staying young at heart , 2017, Science.

[37]  H. Iwata,et al.  Behavior of synthetic polymers immobilized on a cell membrane. , 2008, Biomaterials.

[38]  J. Karp,et al.  Engineered mesenchymal stem cells with self-assembled vesicles for systemic cell targeting. , 2010, Biomaterials.

[39]  Mesenchymal stem cells in cardiac regeneration: a detailed progress report of the last 6 years (2010–2015) , 2016, Stem Cell Research & Therapy.

[40]  Parag Aggarwal,et al.  Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution. , 2008, Molecular pharmaceutics.

[41]  Y. Tang,et al.  Mobilizing of haematopoietic stem cells to ischemic myocardium by plasmid-mediated stromal-cell-derived factor-1α treatment , 2005, Regulatory Peptides.

[42]  Michael Bader,et al.  SDF-1α as a therapeutic stem cell homing factor in myocardial infarction. , 2011, Pharmacology & therapeutics.

[43]  F. Ingegnoli,et al.  Mesenchymal stem cells: potential for therapy and treatment of chronic non-healing skin wounds , 2015, Organogenesis.

[44]  J. Contreras,et al.  NOVEL APPROACH TO XENOTRANSPLANTATION COMBINING SURFACE ENGINEERING AND GENETIC MODIFICATION OF ISOLATED ADULT PORCINE ISLETS. , 2004, Surgery.

[45]  R. Lange,et al.  Cardiac regeneration: current therapies-future concepts. , 2013, Journal of thoracic disease.

[46]  H. Iwata,et al.  Interaction of poly(ethylene glycol)-conjugated phospholipids with supported lipid membranes and their influence on protein adsorption , 2016, Science and technology of advanced materials.

[47]  C. Hodgkinson,et al.  Genetic engineering of mesenchymal stem cells and its application in human disease therapy. , 2010, Human gene therapy.

[48]  Lambros Kaiktsis,et al.  Wall shear stress: theoretical considerations and methods of measurement. , 2007, Progress in cardiovascular diseases.

[49]  Jeffrey A. Hubbell,et al.  Thin Polymer Layers Formed by Polyelectrolyte Multilayer Techniques on Biological Surfaces , 1999 .

[50]  Nalinkanth G. Veerabadran,et al.  Nanoencapsulation of stem cells within polyelectrolyte multilayer shells. , 2007, Macromolecular bioscience.

[51]  J. Karp,et al.  Chemistry and material science at the cell surface. , 2010, Materials today.

[52]  E. Marbán,et al.  c-kit+ Cells Minimally Contribute Cardiomyocytes to the Heart , 2014, Nature.

[53]  S. Simon,et al.  Multifactorial Experimental Design to Optimize the Anti‐Inflammatory and Proangiogenic Potential of Mesenchymal Stem Cell Spheroids , 2017, Stem cells.

[54]  S. Zimmerman,et al.  Engineering the Surface of Therapeutic "Living" Cells. , 2018, Chemical reviews.

[55]  J. Groves,et al.  A chemical approach to unraveling the biological function of the glycosylphosphatidylinositol anchor , 2007, Proceedings of the National Academy of Sciences.

[56]  W. Xue,et al.  Hypoxic preconditioning advances CXCR4 and CXCR7 expression by activating HIF-1α in MSCs. , 2010, Biochemical and biophysical research communications.

[57]  K. Lim,et al.  Cell surface-engineering to embed targeting ligands or tracking agents on the cell membrane. , 2017, Biochemical and biophysical research communications.

[58]  B. Grant,et al.  Pathways and mechanisms of endocytic recycling , 2009, Nature Reviews Molecular Cell Biology.

[59]  H. Iwata,et al.  Interaction between cells and poly(ethylene glycol)-lipid conjugates. , 2015, Colloids and surfaces. B, Biointerfaces.

[60]  B. Sanchez,et al.  Online monitoring of myocardial bioprosthesis for cardiac repair. , 2014, International journal of cardiology.

[61]  M. Penn Importance of the SDF-1:CXCR4 axis in myocardial repair. , 2009, Circulation research.

[62]  P. Wernet,et al.  Repair of Infarcted Myocardium by Autologous Intracoronary Mononuclear Bone Marrow Cell Transplantation in Humans , 2002, Circulation.

[63]  E. Gianolio,et al.  Exofacial protein thiols as a route for the internalization of Gd(III)-based complexes for magnetic resonance imaging cell labeling. , 2010, Journal of medicinal chemistry.

[64]  I. Bellantuono,et al.  A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow. , 2004, Blood.

[65]  J. Hare,et al.  Cardiac regeneration and stem cell therapy , 2008, Current opinion in organ transplantation.

[66]  Teruyuki Nagamune,et al.  Casual cell surface remodeling using biocompatible lipid-poly(ethylene glycol)(n): development of stealth cells and monitoring of cell membrane behavior in serum-supplemented conditions. , 2004, Journal of biomedical materials research. Part A.

[67]  Ping-Pin Zheng,et al.  CAR T cell therapies : ice bucket challenges on glaring safety risks and long-term impacts , 2018 .

[68]  J. Schlenoff,et al.  Cytotoxicity of free versus multilayered polyelectrolytes. , 2011, Biomacromolecules.

[69]  T. Vellai,et al.  Regulation of protein turnover by longevity pathways. , 2010, Advances in experimental medicine and biology.

[70]  Shubiao Zhang,et al.  Toxicity of cationic lipids and cationic polymers in gene delivery. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[71]  R. Herzog,et al.  Progress and prospects: immune responses to viral vectors , 2010, Gene Therapy.

[72]  Ling Wei,et al.  Preconditioning Strategy in Stem Cell Transplantation Therapy , 2013, Translational Stroke Research.

[73]  P. Walczak,et al.  Genetic engineering of stem cells for enhanced therapy. , 2013, Acta neurobiologiae experimentalis.

[74]  A. Zeiher,et al.  Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. , 2006, The New England journal of medicine.

[75]  I. Bellantuono,et al.  bone marrow functionally active CXCR4 receptor capable of promoting migration to A small proportion of mesenchymal stem cells strongly expresses , 2013 .

[76]  K. Curran,et al.  Toxicity and management in CAR T-cell therapy , 2016, Molecular therapy oncolytics.

[77]  C. Wagner,et al.  Programming Cell-Cell Interactions through Non-genetic Membrane Engineering. , 2018, Cell chemical biology.

[78]  Yan Huang,et al.  Stromal Cell–Derived Factor-1α Plays a Critical Role in Stem Cell Recruitment to the Heart After Myocardial Infarction but Is Not Sufficient to Induce Homing in the Absence of Injury , 2004, Circulation.

[79]  J. Contreras,et al.  A novel approach to xenotransplantation combining surface engineering and genetic modification of isolated adult porcine islets. , 2004 .

[80]  L. Wågberg,et al.  Assessment of antibacterial properties of polyvinylamine (PVAm) with different charge densities and hydrophobic modifications. , 2009, Biomacromolecules.

[81]  E. Olson,et al.  Therapeutic approaches for cardiac regeneration and repair , 2018, Nature Reviews Cardiology.

[82]  Jin Han,et al.  Integration of mesenchymal stem cells with nanobiomaterials for the repair of myocardial infarction. , 2015, Advanced drug delivery reviews.

[83]  H. Iwata,et al.  Islet surface modification with urokinase through DNA hybridization. , 2011, Bioconjugate chemistry.

[84]  Darrell J Irvine,et al.  Enhancing Cell therapies from the Outside In: Cell Surface Engineering Using Synthetic Nanomaterials. , 2011, Nano today.

[85]  S. Prabhu,et al.  The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis. , 2016, Circulation research.

[86]  R. Dubridge,et al.  The immunogenicity of humanized and fully human antibodies , 2010, mAbs.

[87]  E. Chaikof,et al.  Surface re-engineering of pancreatic islets with recombinant azido-thrombomodulin. , 2007, Bioconjugate chemistry.

[88]  H. Iwata,et al.  Immobilization of urokinase on the islet surface by amphiphilic poly(vinyl alcohol) that carries alkyl side chains. , 2008, Biomaterials.

[89]  N. Sharpe,et al.  Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. , 2000, Circulation.

[90]  G. Sukhikh,et al.  Mesenchymal Stem Cells , 2002, Bulletin of Experimental Biology and Medicine.

[91]  Mathias Winterhalter,et al.  Protection of mammalian cell used in biosensors by coating with a polyelectrolyte shell. , 2006, Biosensors & bioelectronics.

[92]  J. Molkentin,et al.  The Elusive Progenitor Cell in Cardiac Regeneration: Slip Slidin’ Away , 2017, Circulation research.

[93]  Kam W Leong,et al.  Emerging links between surface nanotechnology and endocytosis: impact on nonviral gene delivery. , 2010, Nano today.

[94]  R. Larsson,et al.  Islet Surface Heparinization Prevents the Instant Blood-Mediated Inflammatory Reaction in Islet Transplantation , 2007, Diabetes.

[95]  D. Irvine,et al.  Active targeting of chemotherapy to disseminated tumors using nanoparticle-carrying T cells , 2015, Science Translational Medicine.

[96]  A. Cerwenka,et al.  Shaping of Natural Killer Cell Antitumor Activity by Ex Vivo Cultivation , 2017, Front. Immunol..

[97]  M. Burnett,et al.  Marrow-Derived Stromal Cells Express Genes Encoding a Broad Spectrum of Arteriogenic Cytokines and Promote In Vitro and In Vivo Arteriogenesis Through Paracrine Mechanisms , 2004, Circulation research.

[98]  Amit N. Patel,et al.  Cell surface engineering to enhance mesenchymal stem cell migration toward an SDF-1 gradient. , 2014, Biomaterials.

[99]  F. Lombardi,et al.  Postinfarct Left Ventricular Remodelling: A Prevailing Cause of Heart Failure , 2016, Cardiology research and practice.

[100]  A. Gliozzi,et al.  Interaction of polyelectrolytes and their composites with living cells. , 2005, Nano letters.

[101]  M. Arai,et al.  Importance of recruitment of bone marrow-derived CXCR4+ cells in post-infarct cardiac repair mediated by G-CSF. , 2006, Cardiovascular research.

[102]  L. Hsieh‐Wilson,et al.  Directing Neuronal Signaling through Cell-Surface Glycan Engineering , 2014, Journal of the American Chemical Society.

[103]  Robert A. Kloner,et al.  Systemic Delivery of Bone Marrow–Derived Mesenchymal Stem Cells to the Infarcted Myocardium: Feasibility, Cell Migration, and Body Distribution , 2003, Circulation.

[104]  C. Yee Journal of Translational Medicine Adoptive T Cell Therapy: Addressing Challenges in Cancer Immunotherapy , 2005 .

[105]  H. Iwata,et al.  Encapsulation of islets with ultra-thin polyion complex membrane through poly(ethylene glycol)-phospholipids anchored to cell membrane. , 2006, Biomaterials.

[106]  M. Burnett,et al.  Local Delivery of Marrow-Derived Stromal Cells Augments Collateral Perfusion Through Paracrine Mechanisms , 2004, Circulation.

[107]  Nouri Nayerossadat,et al.  Viral and nonviral delivery systems for gene delivery , 2012, Advanced biomedical research.

[108]  Michael V Sefton,et al.  Biomaterial-associated thrombosis: roles of coagulation factors, complement, platelets and leukocytes. , 2004, Biomaterials.

[109]  Srinivas Abbina,et al.  Surface Engineering for Cell-Based Therapies: Techniques for Manipulating Mammalian Cell Surfaces. , 2017, ACS biomaterials science & engineering.

[110]  H. Iwata,et al.  Islet-encapsulation in ultra-thin layer-by-layer membranes of poly(vinyl alcohol) anchored to poly(ethylene glycol)-lipids in the cell membrane. , 2007, Biomaterials.

[111]  Joshua M Hare,et al.  Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial. , 2012, JAMA.

[112]  H. Klingemann,et al.  Natural Killer Cells for Immunotherapy – Advantages of the NK-92 Cell Line over Blood NK Cells , 2016, Front. Immunol..

[113]  Harvey T. McMahon,et al.  Molecular mechanism and physiological functions of clathrin-mediated endocytosis , 2011, Nature Reviews Molecular Cell Biology.

[114]  Weimin Fan,et al.  Nanoparticles for tumor targeted therapies and their pharmacokinetics. , 2010, Current drug metabolism.

[115]  Richard T. Lee,et al.  Stem-cell therapy for cardiac disease , 2008, Nature.

[116]  Dong Yun Lee,et al.  Minimization of Immunosuppressive Therapy After Islet Transplantation: Combined Action of Heme Oxygenase‐1 and PEGylation to Islet , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[117]  Youngro Byun,et al.  Functional and histological evaluation of transplanted pancreatic islets immunoprotected by PEGylation and cyclosporine for 1 year. , 2007, Biomaterials.

[118]  Tian Sheng Chen,et al.  Mesenchymal stem cell secretes microparticles enriched in pre-microRNAs , 2009, Nucleic acids research.

[119]  T. Ma,et al.  Preconditioning Stem Cells for In Vivo Delivery , 2014, BioResearch open access.

[120]  E. Chaikof,et al.  Noncovalent cell surface engineering with cationic graft copolymers. , 2009, Journal of the American Chemical Society.

[121]  A. Schambach,et al.  Advantages and applications of CAR-expressing natural killer cells , 2015, Front. Pharmacol..

[122]  Siok-Keen Tey Adoptive T-cell therapy: adverse events and safety switches , 2014, Clinical & translational immunology.

[123]  N. Steinmetz,et al.  Labeling live cells by copper-catalyzed alkyne--azide click chemistry. , 2010, Bioconjugate chemistry.

[124]  A. Curtis,et al.  Cell surface lipids and adhesion. III. The effects on cell adhesion of changes in plasmalemmal lipids. , 1975, Journal of cell science.

[125]  Wen-chao Song,et al.  Complement and its role in innate and adaptive immune responses , 2010, Cell Research.

[126]  Virpi Talman,et al.  Cardiac fibrosis in myocardial infarction—from repair and remodeling to regeneration , 2016, Cell and Tissue Research.

[127]  P. Darcy,et al.  Gene-engineered T cells for cancer therapy , 2013, Nature Reviews Cancer.

[128]  M. Cybulsky,et al.  Getting to the site of inflammation: the leukocyte adhesion cascade updated , 2007, Nature Reviews Immunology.

[129]  S. Rosenberg,et al.  Adoptive cell transfer: a clinical path to effective cancer immunotherapy , 2008, Nature Reviews Cancer.

[130]  O. Lindvall,et al.  Stem cells for the treatment of neurological disorders , 2006, Nature.

[131]  S. Grupp,et al.  Chimeric Antigen Receptor– and TCR-Modified T Cells Enter Main Street and Wall Street , 2015, The Journal of Immunology.

[132]  Eric J Topol,et al.  Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy , 2003, The Lancet.

[133]  S. Rosenberg,et al.  Adoptive cell transfer as personalized immunotherapy for human cancer , 2015, Science.

[134]  T. Iwatsubo,et al.  Pharmacokinetics and tissue distribution of tacrolimus (FK506) after a single or repeated ocular instillation in rabbits. , 2008, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[135]  H. Iwata,et al.  Cryopreserved Agarose-Encapsulated Islets As Bioartificial Pancreas: A Feasibility Study , 2009, Transplantation.

[136]  Debjit Dutta,et al.  Synthetic chemoselective rewiring of cell surfaces: generation of three-dimensional tissue structures. , 2011, Journal of the American Chemical Society.

[137]  Carolyn R. Bertozzi,et al.  Chemical remodelling of cell surfaces in living animals , 2004, Nature.

[138]  N. Hersch,et al.  Novel fusogenic liposomes for fluorescent cell labeling and membrane modification. , 2010, Bioconjugate chemistry.

[139]  H. Iwata,et al.  Surface plasmon resonance and surface plasmon field-enhanced fluorescence spectroscopy for sensitive detection of tumor markers. , 2009, Methods in molecular biology.